WRF
IMMU

Waddell & Reed Financial’s Immunomedics Inc IMMU Stock Holding History

Waddell & Reed Financial’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,334,212
Closed -$33.3M – 536
2018
Q4 		$33.3M Buy
2,334,212
+1,581,896
+210% +$31.4M 0.09% 256
2018
Q3 		$15.7M Buy
+752,316
New +$17.8M 0.03% 371

Other funds holding IMMU

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Waddell & Reed Financial's IMMU Position: Q1 2019 in Review

Waddell & Reed Financial sold out of Immunomedics Inc (IMMU) in Q1 2019, closing a stake of 2,334,212 shares — an estimated $33.3M sold.

Waddell & Reed Financial first reported a position in IMMU in Q3 2018 and held it in 2 quarters. The position peaked at $33.3M in Q4 2018. 204 funds tracked by Wall St. Rank hold IMMU as of Q1 2019.

  • Waddell & Reed Financial reported no remaining Immunomedics Inc position as of Q1 2019 after selling out during the quarter.
  • Waddell & Reed Financial sold 2,334,212 Immunomedics Inc shares in Q1 2019, an estimated $33.3M.
  • Waddell & Reed Financial first reported a position in Immunomedics Inc in Q3 2018 and held it in 2 quarters.
  • Waddell & Reed Financial's Immunomedics Inc position peaked at $33.3M in Q4 2018.
  • 204 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2019.

Based on Waddell & Reed Financial's 13F filing for Q1 2019, filed 15 May 2019.